The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
We have started a new chapter in the Blood Service story, and are now innovating and growing by extending our infrastructure and capabilities to support the healthcare industry and ultimately deliver improved patient outcomes.
Located at the Monash Institute of Pharmaceutical Sciences, Drug Delivery, Disposition and Dynamics, the HMS Trust Laboratory is a new facility bringing together state of the art equipment for chemical analysis and solid state characterisation.
Featuring a wide range of capabilities in surface modification, thin films, polymer grafting, biomolecule immobilisation and bioactive coatings in polymers, ceramics and metals.
An industry leader in imaging, flow cytometry, project design, analysis and training providing easy, open access to equipment and experienced staff for researchers from any field
Established through a $2 million grant from the Australian Cancer Research Foundation, the Centre includes a Mediso Nanoscan PET/MRI Imaging Platform, a Mediso Nanoscan SPECT/CT Imaging Platform and an IVIS Spectrum Bioluminescent and Fluorescence Imaging Unit for medical research and preclinical investigations.
RoboCore is a fee-for-service facility offering access to expertise and state-of-the-art automated liquid handling and assay automation instrumentation. Applications include ELISA, sample preparation, chemical and biological library aliquoting, cell culture and tube labelling.
The Monash Protein Production Unit is a specialised protein production and purification facility. We have expertise in the production of recombinant proteins involving the generation of DNA constructs through to biophysical analysis of recombinant purified proteins.
MATF is a global source of cost effective, high quality, high affinity, custom monoclonal antibodies. We are known for our ability to succeed at challenging projects and strive to be the best at producing monoclonal antibodies where others have failed.
The HTCS Facility houses a Lead Discovery library currently containing ~200,000 compounds and robotics platforms to screen these small molecule chemical entities against biological targets of interest for drug discovery or for chemical biology outcomes
The facility is equipped for patch-clamp electrophysiology, allowing plasma-membrane ion-channel or transporter activity to be recorded in whole-cell or excised membrane patch configurations,
The Zetasizer Nano ZS (Malvern Instruments, UK) instrument uses light scattering techniques to determine the size distribution profile of particles in suspension.
The Drug Delivery Disposition and Dynamics (D4) Theme at the Monash Institute of Pharmaceutical Sciences provides expertise and infrastructure in drug formulation and drug delivery system design and assessment and evaluation of drug formulations/delivery systems in pre-clinical animal models.
The DNA & Blood Profiling Facility integrates proteomics, lipidomics, metabolomics, genomics and epigenomics so health problems can be examined from a multifaceted viewpoint
Development, validation and small- to mid-scale manufacture of ELISA and rapid, point of care diagnostic assays for proteins or antibodies of interest. Documentation and technology transfer to end manufacturers
The Burnet ImmunoMonitoring Facility is accredited in NATA's R&D Program and offers immunological testing and sample biobanking for vaccine manufacturers, biotechnology and pharmaceutical companies, universities, and research institutes involved in translational research and development of novel therapies.
The Victorian Centre for Functional Genomics at the Peter MacCallum Cancer Centre provides the infrastructure and expertise to perform small interfering (siRNA), micro RNA (miRNA), long non-coding RNA (lncRNA) and lentiviral-based short hairpin RNAi (shRNAmir) knockdown screens for functional genomics studies.